London close: Stocks slip on slew of UK data
30th Jun 2025 17:40
(Sharecast News) - London stocks ended lower on Monday as investors digested a series of UK economic data and monitored developments in North American trade negotiations.
Read moreIndivior to cancel secondary listing in London
2nd Jun 2025 08:28
(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.
Read moreIndivior shrinks board following pressure from activist investor
4th Mar 2025 09:32
(Sharecast News) - Indivior has further overhauled its board, including reducing its size, following pressure from activist investor Oaktree Capital Management.
Read moreLondon close: Stocks mixed on corporate earnings, Trump tariff threats
27th Feb 2025 15:43
(Sharecast News) - London stocks closed in a mixed state on Thursday, with the top-flight index recovering from a weaker open as investors absorbed fresh US jobless claims data and a wave of corporate earnings reports.
Read morePharma veteran Ciaffoni to take CEO reins at Indivior
27th Feb 2025 08:37
(Sharecast News) - Indivior announced the appointment of Joe Ciaffoni as its next chief executive officer on Thursday, subject to shareholder approval of a new remuneration policy at its annual general meeting in May.
Read moreLondon close: Stocks slip as US jobless claims rise
20th Feb 2025 16:06
(Sharecast News) - London equities ended lower on Thursday as investors reacted to a higher-than-expected rise in US jobless claims and a decline in UK consumer confidence.
Read moreIndivior ends year better than expected, flags tough 2025
20th Feb 2025 09:09
(Sharecast News) - Shares in Indivior were sliding on Thursday, even after it reported a better-than-expected end to a difficult year, with a 9% increase in full-year 2024 net revenue to $1.19bn amid continued growth in its opioid use disorder treatment Sublocade.
Read moreLondon close: Stocks mixed as US inflation comes in hot
12th Feb 2025 16:59
(Sharecast News) - London stocks closed in a mixed state on Wednesday, as markets reacted to a stronger-than-expected inflation reading from the United States.
Read moreIndivior flags delay to FDA review of Sublocade label change
12th Feb 2025 07:24
(Sharecast News) - Indivior announced a delay in the US Food and Drug Administration's (FDA) final review of proposed label changes for its 'Sublocade', or buprenorphine extended-release, injection on Wednesday.
Read moreIndivior makes board changes after move to Nasdaq
17th Dec 2024 10:02
(Sharecast News) - Indivior announced changes to its board of directors on Tuesday, following discussions with Oaktree Capital Management, which advises funds holding a stake in the company.
Read moreOaktree Capital calls on Indivior to refresh board of directors
7th Nov 2024 20:03
(Sharecast News) - Investment fund Oaktree Capital Management has written to Indivior urging the opioid addiction treatment maker to refresh its board with directors "committed to taking all steps necessary to improve shareholder value".
Read moreLondon close: Stocks mixed after barrage of corporate updates
24th Oct 2024 09:37
(Sharecast News) - London's stock markets ended Thursday with mixed results, with the top-flight index held aloft by strong earnings reports from major companies like Unilever and Barclays, as investors digested a slew of US data.
Read moreIndivior confident after strong third quarter
24th Oct 2024 08:22
(Sharecast News) - Addiction treatment specialist Indivior reported a strong third-quarter performance on Thursday, with total net revenue increasing 13% to $307m compared to the same period last year, after it recently updated its full-year guidance.
Read moreLondon close: Stocks red as US inflation, jobless claims top forecasts
10th Oct 2024 14:58
(Sharecast News) - London's stock markets ended Thursday in negative territory as investors weighed a higher-than-expected inflation and jobless claims readings out of the United States.
Read moreIndivior shares tank after another profit warning
10th Oct 2024 12:38
(Sharecast News) - Shares in Indivior plunged on Thursday after the pharma group cut its full-year revenue forecast for the second times following a weaker-than-expected third-quarter performance from Sublocade, its treatment of moderate to severe opioid use disorder.
Read more